Masahiro Serikawa

8PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 16, 2025
Clinicopathological Features of Small Pancreatic Neuroendocrine Neoplasms 10 mm or Smaller.

Tetsuro Hirano, Masahiro Serikawa, Yasutaka Ishii

|Nov 14, 2023
The Significance of Histopathological Findings on Clinical Outcomes in Endoscopic Papillectomy with Endocut.

Sayaka Miyamoto, Masahiro Serikawa, Yasutaka Ishii

|Nov 14, 2023
Optimal Lymphadenectomy in Patients with Well-Differentiated Nonfunctioning Pancreatic Neuroendocrine Neoplasms.

Ryuta Shintakuya, Kenichiro Uemura, Tatsuaki Sumiyoshi

|Oct 14, 2023
Utility of Covered Self-Expanding Metal Stents for Biliary Drainage during Neoadjuvant Chemotherapy in Patients with Borderline Resectable Pancreatic Cancer.

Masaru Furukawa, Yasutaka Ishii, Masahiro Serikawa

|Sep 09, 2023
Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment.

Yosuke Tamura, Atsushi Ono, Hikaru Nakahara

|Aug 26, 2023
Diagnostic Ability and Safety of Repeated Pancreatic Juice Cytology Using an Endoscopic Nasopancreatic Drainage Catheter for Pancreatic Ductal Adenocarcinoma: A Multicenter Prospective Study.

Shinya Nakamura, Yasutaka Ishii, Masahiro Serikawa

Pageof 2

Frequent Collaborators

7 joint publications

Yasutaka Ishii

5 joint publications

Juri Ikemoto

2 joint publications

Shinya Nakamura

2 joint publications

Kenichiro Uemura